Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Passage Bio (PASG)
NASDAQ:PASG
Passage Bio (PASG) Stock Price & Analysis
397 Followers
PASG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.58 - $1.79
Previous Close$1.23
Volume21.91K
Average Volume (3M)360.82K
Market Cap
$76.69M
Enterprise Value-$12.22M
Total Cash (Recent Filing)$114.29M
Total Debt (Recent Filing)$26.29M
Price to Earnings (P/E)-0.7
Beta1.19
Next Earnings
May 13, 2024EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.86
Shares Outstanding55,598,796
10 Day Avg. Volume170,745
30 Day Avg. Volume360,820
Standard Deviation0.23
R-Squared0.09
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.67
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.12
Forecast
1Y Price Target
$14.00Price Target Upside1024.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Passage Bio News
PremiumCompany Announcements
New Innovation / R&D Risk for Passage Bio, Inc. – What’s the Latest?
PremiumCompany Announcements
Passage Bio Welcomes Kathleen Borthwick as New CFO
Ownership Overview
47.37% Insiders
5.22% Mutual Funds
3.49% Other Institutional Investors
43.92% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PASG FAQ
What was Passage Bio’s price range in the past 12 months?
Passage Bio lowest stock price was $0.57 and its highest was $1.79 in the past 12 months.
What is Passage Bio’s market cap?
Currently, no data Available
When is Passage Bio’s upcoming earnings report date?
Passage Bio’s upcoming earnings report date is May 13, 2024 which is in 24 days.
How were Passage Bio’s earnings last quarter?
Passage Bio released its earnings results on Mar 04, 2024. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.386 by $0.086.
Is Passage Bio overvalued?
According to Wall Street analysts Passage Bio’s price is currently Undervalued.
Does Passage Bio pay dividends?
Passage Bio does not currently pay dividends.
What is Passage Bio’s EPS estimate?
Passage Bio’s EPS estimate is -$0.36.
How many shares outstanding does Passage Bio have?
Passage Bio has 61,611,797 shares outstanding.
What happened to Passage Bio’s price movement after its last earnings report?
Passage Bio reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.386. Following the earnings report the stock price went up 1.183%.
Which hedge fund is a major shareholder of Passage Bio?
Among the largest hedge funds holding Passage Bio’s share is Versant Venture Management, LLC. It holds Passage Bio’s shares valued at 5M.
---
Passage Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.00 (1024.77% Upside)
$14.00 (1024.77% Upside)
Blogger Sentiment
Bullish
PASG Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 6.8%
Last 30 Days ▼ 6.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.95%
12-Months-Change
Fundamentals
Return on Equity
-65.29%
Trailing 12-Months
Asset Growth
-38.19%
Trailing 12-Months
Company Description
Passage Bio
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
---
PASG Company Deck
---
PASG Earnings Call
Q4 2023
0:00 / 0:00
---
PASG Stock 12 Months Forecast
Average Price Target
$14.00
▲(1024.77% Upside)
Technical Analysis
Best Analysts Covering PASG
1 Year
1 Year Success Rate
6/12 ratings generated profit
1 Year Average Return
-6.14%
reiterated a buy rating 4 months ago
Copying Geulah Livshits's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -6.14% per trade.
---